More about

Autoimmune Hepatitis

News
October 30, 2019
2 min read
Save

Autoimmune liver disease requires lifelong monitoring as presentation may change

Autoimmune liver disease requires lifelong monitoring as presentation may change

SAN ANTONIO — At this year’s National Liver Congress, Gideon M. Hirschfield, MD, presented real-life cases of patients with primary sclerosing cholangitis along with an overview of how autoimmune liver disease may change over time from initial presentation.

News
October 18, 2019
2 min read
Save

Large duct injury in autoimmune liver disease may stunt T cell therapy benefit

CHICAGO — Large duct injury in pediatric patients with primary sclerosing cholangitis and autoimmune sclerosing cholangitis correlated with a distinct pattern of hepatic gene expression, which may limit benefits from T cell-directed immunosuppressive therapy, according to a study presented at NASPGHAN 2019.

View more